| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 3.26e-12 | 43 | 176 | 10 | GO:0030280 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 TPR MYH2 MYH9 EPS8L2 HIP1 CTNNAL1 SPATA31A3 MYO5A CENPE CENPF HAP1 SYNE1 DYRK1A EPS8L1 CCDC88B JAKMIP2 SPAG5 HOOK3 DST MYH14 SSH3 SIPA1L1 PDCD5 MACF1 MYH15 DIXDC1 KIF17 UTRN FMNL1 NIN | 8.11e-09 | 1099 | 176 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH9 EPS8L2 HIP1 CTNNAL1 SPATA31A3 MYO5A SYNE1 DYRK1A EPS8L1 DST MYH14 SSH3 SIPA1L1 MACF1 MYH15 DIXDC1 UTRN FMNL1 | 5.02e-08 | 479 | 176 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH9 EPS8L2 HIP1 CTNNAL1 MYO5A SYNE1 EPS8L1 MYH14 SIPA1L1 MACF1 MYH15 FMNL1 | 1.16e-07 | 227 | 176 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.03e-06 | 118 | 176 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural molecule activity | ROCK2 TPR KRT4 HIP1 KRT81 KRT83 KRT85 KRT86 LAMA3 LMNTD2 EVPL COL6A5 KRT79 KRT87P KRT73 NUP205 KRT23 DST KRT75 KRT71 MACF1 ACTL9 MRPL46 NUP160 | 1.09e-06 | 891 | 176 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.99e-05 | 38 | 176 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | tubulin binding | TPR CENPE CENPF DYRK1A CCDC88B JAKMIP2 SPAG5 HOOK3 DST PDCD5 MACF1 DIXDC1 KIF17 NIN | 2.76e-05 | 428 | 176 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH9 MYO5A CENPE PSMC5 RNF213 ABCA10 MSH6 ATP6V0D1 CLPB MYH14 MACF1 MYH15 POLQ KIF17 DNAH8 DNAH9 | 3.20e-05 | 614 | 176 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | latrotoxin receptor activity | 7.73e-05 | 2 | 176 | 2 | GO:0016524 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.01e-04 | 28 | 176 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | pantetheine hydrolase activity | 2.30e-04 | 3 | 176 | 2 | GO:0017159 | |
| GeneOntologyMolecularFunction | microtubule binding | 4.20e-04 | 308 | 176 | 10 | GO:0008017 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | EPS8L2 RAP1GDS1 RGPD8 TBC1D30 SH3BP1 EPS8L1 TBC1D9 SRGAP1 SIPA1L1 DEF6 KNDC1 GPSM2 RGPD5 | 5.78e-04 | 507 | 176 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | EPS8L2 RAP1GDS1 RGPD8 TBC1D30 SH3BP1 EPS8L1 TBC1D9 SRGAP1 SIPA1L1 DEF6 KNDC1 GPSM2 RGPD5 | 5.78e-04 | 507 | 176 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 6.56e-04 | 45 | 176 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.34e-03 | 25 | 176 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | dynein complex binding | 1.88e-03 | 28 | 176 | 3 | GO:0070840 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT23 DST KRT75 KRT71 MACF1 | 1.41e-13 | 99 | 177 | 14 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT23 DST KRT75 KRT71 MACF1 | 1.63e-13 | 100 | 177 | 14 | GO:0045103 |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT4 KRT81 KRT83 KRT85 KRT86 KRT79 KRT87P KRT73 KRT23 KRT75 KRT71 | 4.14e-11 | 75 | 177 | 11 | GO:0045109 |
| GeneOntologyBiologicalProcess | keratinization | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT75 KRT71 | 2.16e-10 | 87 | 177 | 11 | GO:0031424 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | ROCK2 KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT75 KRT71 | 8.93e-08 | 189 | 177 | 12 | GO:0030216 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | ROCK2 KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KEAP1 KRT79 KRT87P KRT73 KRT75 KRT71 | 1.11e-06 | 284 | 177 | 13 | GO:0009913 |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 TPR MYH9 MYO5A CENPE CCDC146 HAP1 DYRK1A ATAT1 CCDC88B SPAG5 CFAP65 HOOK3 DST CEP250 PDE4DIP GPSM2 MACF1 TEKT4 DIXDC1 PARD3 KIF17 DNAH8 DNAH9 CCDC40 NIN | 1.27e-06 | 1058 | 177 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ROCK2 PLXNA3 TPR NPR2 MYH9 EPS8L2 HIP1 CENPE HAP1 SYNE1 AZU1 DEF8 PSMC5 ADGRL1 EPS8L1 ATAT1 SPAG5 FBXW8 AP2M1 PDCD5 PDE4DIP GPSM2 MACF1 PLA2G6 DIXDC1 IKBKB PARD3 ADGRL2 PLXNA1 NIN | 1.81e-06 | 1366 | 177 | 30 | GO:0051130 |
| GeneOntologyBiologicalProcess | epidermis development | ROCK2 KRT4 TRPC4AP MYO5A KRT81 KRT83 KRT85 KRT86 LAMA3 EVPL KEAP1 KRT79 KRT87P KRT73 KRT75 KRT71 | 2.45e-06 | 461 | 177 | 16 | GO:0008544 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 TPR MYH9 CENPE CCDC146 DYRK1A ATAT1 CCDC88B SPAG5 CFAP65 HOOK3 DST CEP250 PDE4DIP GPSM2 DIXDC1 PARD3 DNAH8 CCDC40 NIN | 3.99e-06 | 720 | 177 | 20 | GO:0000226 |
| GeneOntologyBiologicalProcess | skin development | ROCK2 KRT4 TRPC4AP MYO5A KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT75 KRT71 | 4.39e-06 | 373 | 177 | 14 | GO:0043588 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ROCK2 KRT4 MYH9 HIP1 RAP1GDS1 MYO5A KRT81 KRT83 KRT85 KRT86 SH3BP1 DYRK1A KRT79 KRT87P CCDC88B KRT73 KRT23 HOOK3 KRT75 KRT71 SSH3 PDE4DIP NIN | 7.98e-06 | 957 | 177 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | organelle assembly | TPR AGO2 TBC1D30 CENPE ACRBP CENPF CCDC146 HAP1 SYNE1 ATG2B RNF213 ATAT1 SPAG5 CFAP65 NEK1 FBXW8 ATP6V0D1 SIPA1L1 CEP250 GPSM2 TEKT4 ACTL9 SCLT1 DNAH8 CCDC40 | 1.46e-05 | 1138 | 177 | 25 | GO:0070925 |
| GeneOntologyBiologicalProcess | cilium organization | TBC1D30 CCDC146 HAP1 SYNE1 ATAT1 CFAP65 NEK1 FBXW8 ATP6V0D1 CEP250 TEKT4 SCLT1 KIF17 DNAH8 CCDC40 | 1.61e-05 | 476 | 177 | 15 | GO:0044782 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPS8L2 TBC1D30 CCDC146 HAP1 SYNE1 SH3BP1 DEF8 EPS8L1 ATAT1 CFAP65 NEK1 FBXW8 ATP6V0D1 CEP250 TEKT4 SCLT1 DNAH8 CCDC40 | 1.95e-05 | 670 | 177 | 18 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | EPS8L2 TBC1D30 CCDC146 HAP1 SYNE1 SH3BP1 DEF8 EPS8L1 ATAT1 CFAP65 NEK1 FBXW8 ATP6V0D1 CEP250 TEKT4 SCLT1 DNAH8 CCDC40 | 2.61e-05 | 685 | 177 | 18 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | TBC1D30 CCDC146 HAP1 SYNE1 ATAT1 CFAP65 NEK1 FBXW8 ATP6V0D1 CEP250 TEKT4 SCLT1 DNAH8 CCDC40 | 3.09e-05 | 444 | 177 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | ROCK2 TPR HAP1 DYRK1A ATAT1 SPAG5 PDE4DIP GPSM2 MACF1 DIXDC1 CCDC40 | 4.77e-05 | 293 | 177 | 11 | GO:0032886 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ROCK2 KRT4 KDM5B NPR2 KRT81 KRT83 KRT85 KRT86 SH3BP1 EVPL KEAP1 KRT79 KRT87P KRT73 KRT23 KRT75 KRT71 GPSM2 IKBKB PARD3 | 6.05e-05 | 870 | 177 | 20 | GO:0030855 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 7.32e-05 | 2 | 177 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | hypothalamus cell differentiation | 2.11e-04 | 14 | 177 | 3 | GO:0021979 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 2.18e-04 | 3 | 177 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ROCK2 TPR TRAF2 MYH9 EPS8L2 TBC1D30 HAP1 SYNE1 DEF8 DYRK1A PSMC5 ADGRL1 EPS8L1 ATAT1 SPAG5 SSH3 SIPA1L1 PDE4DIP GPSM2 MACF1 PLA2G6 IKBKB ADGRL2 | 2.22e-04 | 1189 | 177 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | centrosome localization | 2.23e-04 | 35 | 177 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.49e-04 | 36 | 177 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | positive regulation of ruffle assembly | 2.62e-04 | 15 | 177 | 3 | GO:1900029 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 3.91e-04 | 257 | 177 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 4.34e-04 | 4 | 177 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 4.77e-04 | 115 | 177 | 6 | GO:0018107 | |
| GeneOntologyCellularComponent | intermediate filament | KRT4 MYO5A KRT81 KRT83 KRT85 KRT86 DYRK1A LMNTD2 EVPL KRT79 KRT87P KRT73 KRT23 DST KRT75 KRT71 MACF1 | 1.00e-11 | 227 | 177 | 17 | GO:0005882 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT4 MYH2 MYH9 MYO5A CENPE KRT81 KRT83 SYNE1 KRT85 KRT86 DYRK1A LMNTD2 EVPL KEAP1 ATAT1 KRT79 KRT87P RYR3 SPAG5 KRT73 KRT23 HOOK3 DST KRT75 KRT71 MYH14 PDE4DIP MACF1 MYH15 TEKT4 ACTL9 KIF17 DNAH8 DNAH9 NIN | 6.44e-11 | 1179 | 177 | 35 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT4 MYH2 MYH9 MYO5A CENPE KRT81 KRT83 SYNE1 KRT85 KRT86 DYRK1A LMNTD2 EVPL KEAP1 ATAT1 KRT79 KRT87P RYR3 SPAG5 KRT73 KRT23 HOOK3 DST KRT75 KRT71 MYH14 PDE4DIP MACF1 MYH15 TEKT4 ACTL9 KIF17 DNAH8 DNAH9 NIN | 7.75e-11 | 1187 | 177 | 35 | GO:0099081 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT4 MYO5A KRT81 KRT83 KRT85 KRT86 DYRK1A LMNTD2 EVPL KRT79 KRT87P KRT73 KRT23 DST KRT75 KRT71 MACF1 | 1.03e-10 | 263 | 177 | 17 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT4 MYH9 MYO5A CENPE KRT81 KRT83 KRT85 KRT86 DYRK1A LMNTD2 EVPL KEAP1 ATAT1 KRT79 KRT87P SPAG5 KRT73 KRT23 HOOK3 DST KRT75 KRT71 PDE4DIP MACF1 TEKT4 ACTL9 KIF17 DNAH8 DNAH9 NIN | 1.15e-10 | 899 | 177 | 30 | GO:0099513 |
| GeneOntologyCellularComponent | keratin filament | 9.78e-09 | 97 | 177 | 10 | GO:0045095 | |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 CDC42BPG EPS8L2 TGIF2 TBC1D30 CENPF CCDC146 HAP1 ANKRD26 KEAP1 CCDC88B BIRC6 SPAG5 NEK1 FBXW8 HOOK3 ATP6V0D1 CROCC2 CEP250 PDE4DIP GPSM2 TTC39A SCLT1 KIF17 NIN | 2.55e-07 | 919 | 177 | 25 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | ROCK2 CDC42BPG EPS8L2 TGIF2 CENPF CCDC146 HAP1 ANKRD26 KEAP1 CCDC88B BIRC6 SPAG5 NEK1 HOOK3 ATP6V0D1 CROCC2 CEP250 PDE4DIP GPSM2 TTC39A SCLT1 NIN | 6.36e-07 | 770 | 177 | 22 | GO:0005813 |
| GeneOntologyCellularComponent | myosin filament | 5.47e-05 | 25 | 177 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 6.86e-05 | 10 | 177 | 3 | GO:0097539 | |
| GeneOntologyCellularComponent | myosin II complex | 8.68e-05 | 28 | 177 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH9 HIP1 MYO5A HAP1 DYRK1A ANKRD26 KEAP1 DST MYH14 SIPA1L1 MACF1 MYH15 DIXDC1 ACTL9 | 1.20e-04 | 576 | 177 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 1.42e-04 | 59 | 177 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | spindle | ROCK2 TPR MYH9 CENPE CENPF ATAT1 BIRC6 SPAG5 CEP250 GPSM2 CD180 PARD3 NIN | 1.96e-04 | 471 | 177 | 13 | GO:0005819 |
| GeneOntologyCellularComponent | contractile ring | 2.03e-04 | 14 | 177 | 3 | GO:0070938 | |
| GeneOntologyCellularComponent | myosin II filament | 2.13e-04 | 3 | 177 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | nuclear pore | 2.21e-04 | 101 | 177 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | cell cortex | MYH2 TRAF2 MYH9 HIP1 SH3BP1 DST PDE4DIP GPSM2 MACF1 PARD3 FMNL1 | 3.36e-04 | 371 | 177 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | microtubule | CENPE DYRK1A ATAT1 SPAG5 HOOK3 DST PDE4DIP MACF1 TEKT4 KIF17 DNAH8 DNAH9 NIN | 6.36e-04 | 533 | 177 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | centriole | 6.71e-04 | 172 | 177 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | inclusion body | 1.01e-03 | 90 | 177 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.03e-03 | 185 | 177 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | clathrin coat | 1.29e-03 | 56 | 177 | 4 | GO:0030118 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 1.46e-03 | 7 | 177 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.66e-03 | 201 | 177 | 7 | GO:0072686 | |
| GeneOntologyCellularComponent | cilium | NPR2 EVC2 TBC1D30 MYO5A CENPF SPAG5 CFAP65 FBXW8 CEP250 TEKT4 SCLT1 KIF17 DNAH8 DNAH9 ANKS3 CCDC40 NIN | 1.66e-03 | 898 | 177 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | microtubule plus-end | 1.67e-03 | 28 | 177 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.67e-03 | 28 | 177 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | spindle pole | 1.85e-03 | 205 | 177 | 7 | GO:0000922 | |
| HumanPheno | Perifollicular hyperkeratosis | 7.50e-06 | 4 | 64 | 3 | HP:0007468 | |
| Domain | Keratin_II | 8.51e-13 | 26 | 168 | 9 | IPR003054 | |
| Domain | Keratin_2_head | 2.36e-11 | 24 | 168 | 8 | IPR032444 | |
| Domain | Keratin_2_head | 2.36e-11 | 24 | 168 | 8 | PF16208 | |
| Domain | Intermediate_filament_CS | 2.25e-10 | 63 | 168 | 10 | IPR018039 | |
| Domain | IF | 8.79e-10 | 72 | 168 | 10 | PS00226 | |
| Domain | Filament | 1.01e-09 | 73 | 168 | 10 | PF00038 | |
| Domain | IF | 1.52e-09 | 76 | 168 | 10 | IPR001664 | |
| Domain | Filament | 1.44e-08 | 71 | 168 | 9 | SM01391 | |
| Domain | Biotinidase_euk | 2.84e-06 | 4 | 168 | 3 | IPR012101 | |
| Domain | Spectrin_repeat | 5.53e-06 | 29 | 168 | 5 | IPR002017 | |
| Domain | Myosin_N | 7.98e-06 | 15 | 168 | 4 | PF02736 | |
| Domain | Myosin_N | 7.98e-06 | 15 | 168 | 4 | IPR004009 | |
| Domain | SPEC | 9.18e-06 | 32 | 168 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.18e-06 | 32 | 168 | 5 | IPR018159 | |
| Domain | - | 1.40e-05 | 6 | 168 | 3 | 3.90.1290.10 | |
| Domain | Myosin_tail_1 | 1.75e-05 | 18 | 168 | 4 | PF01576 | |
| Domain | Myosin_tail | 1.75e-05 | 18 | 168 | 4 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 2.19e-05 | 38 | 168 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.19e-05 | 38 | 168 | 5 | PS51456 | |
| Domain | Myosin_head | 2.19e-05 | 38 | 168 | 5 | PF00063 | |
| Domain | MYSc | 2.19e-05 | 38 | 168 | 5 | SM00242 | |
| Domain | Myosin-like_IQ_dom | 2.20e-05 | 19 | 168 | 4 | IPR027401 | |
| Domain | - | 2.20e-05 | 19 | 168 | 4 | 4.10.270.10 | |
| Domain | Plectin | 2.44e-05 | 7 | 168 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.44e-05 | 7 | 168 | 3 | IPR001101 | |
| Domain | PLEC | 2.44e-05 | 7 | 168 | 3 | SM00250 | |
| Domain | CH | 2.58e-05 | 65 | 168 | 6 | SM00033 | |
| Domain | - | 3.87e-05 | 8 | 168 | 3 | 3.60.110.10 | |
| Domain | C-N_Hydrolase | 3.87e-05 | 8 | 168 | 3 | IPR003010 | |
| Domain | CN_hydrolase | 3.87e-05 | 8 | 168 | 3 | PF00795 | |
| Domain | CN_HYDROLASE | 3.87e-05 | 8 | 168 | 3 | PS50263 | |
| Domain | CH | 3.95e-05 | 70 | 168 | 6 | PF00307 | |
| Domain | - | 4.28e-05 | 71 | 168 | 6 | 1.10.418.10 | |
| Domain | Spectrin | 4.89e-05 | 23 | 168 | 4 | PF00435 | |
| Domain | ACTININ_2 | 4.89e-05 | 23 | 168 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.89e-05 | 23 | 168 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.89e-05 | 23 | 168 | 4 | IPR001589 | |
| Domain | CH | 5.01e-05 | 73 | 168 | 6 | PS50021 | |
| Domain | ENTH | 5.77e-05 | 9 | 168 | 3 | PS50942 | |
| Domain | ENTH | 5.77e-05 | 9 | 168 | 3 | SM00273 | |
| Domain | CH-domain | 5.84e-05 | 75 | 168 | 6 | IPR001715 | |
| Domain | ENTH | 8.19e-05 | 10 | 168 | 3 | IPR013809 | |
| Domain | Znf_TRAF | 1.48e-04 | 12 | 168 | 3 | IPR001293 | |
| Domain | ZF_TRAF | 1.91e-04 | 13 | 168 | 3 | PS50145 | |
| Domain | Ser-tRNA-synth_1_N | 2.40e-04 | 3 | 168 | 2 | IPR015866 | |
| Domain | - | 2.40e-04 | 3 | 168 | 2 | 1.10.287.40 | |
| Domain | Latrophilin | 2.40e-04 | 3 | 168 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 2.40e-04 | 3 | 168 | 2 | IPR003334 | |
| Domain | EPS8_PTB | 4.77e-04 | 4 | 168 | 2 | IPR033928 | |
| Domain | Prefoldin | 4.77e-04 | 72 | 168 | 5 | IPR009053 | |
| Domain | Gal_Lectin | 7.90e-04 | 5 | 168 | 2 | PF02140 | |
| Domain | GPCR_2_latrophilin | 7.90e-04 | 5 | 168 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 7.90e-04 | 5 | 168 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 7.90e-04 | 5 | 168 | 2 | PS50228 | |
| Domain | GAR | 1.18e-03 | 6 | 168 | 2 | PS51460 | |
| Domain | HOOK | 1.18e-03 | 6 | 168 | 2 | PF05622 | |
| Domain | GAS2 | 1.18e-03 | 6 | 168 | 2 | PF02187 | |
| Domain | ENTH | 1.18e-03 | 6 | 168 | 2 | PF01417 | |
| Domain | Hook-related_fam | 1.18e-03 | 6 | 168 | 2 | IPR008636 | |
| Domain | - | 1.18e-03 | 6 | 168 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.18e-03 | 6 | 168 | 2 | IPR003108 | |
| Domain | GAS2 | 1.18e-03 | 6 | 168 | 2 | SM00243 | |
| Domain | TRAF-like | 1.26e-03 | 24 | 168 | 3 | IPR008974 | |
| Domain | IQ | 1.52e-03 | 93 | 168 | 5 | PS50096 | |
| Domain | - | 1.60e-03 | 26 | 168 | 3 | 1.25.40.90 | |
| Domain | AAA | 1.94e-03 | 144 | 168 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.94e-03 | 144 | 168 | 6 | IPR003593 | |
| Domain | PTB | 2.17e-03 | 8 | 168 | 2 | IPR013625 | |
| Domain | DHC_N1 | 2.17e-03 | 8 | 168 | 2 | PF08385 | |
| Domain | zf-TRAF | 2.17e-03 | 8 | 168 | 2 | PF02176 | |
| Domain | PTB | 2.17e-03 | 8 | 168 | 2 | PF08416 | |
| Domain | Dynein_heavy_dom-1 | 2.17e-03 | 8 | 168 | 2 | IPR013594 | |
| Domain | ENTH_VHS | 2.20e-03 | 29 | 168 | 3 | IPR008942 | |
| Domain | Plexin_cytopl | 2.78e-03 | 9 | 168 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.78e-03 | 9 | 168 | 2 | IPR013548 | |
| Domain | Plexin | 2.78e-03 | 9 | 168 | 2 | IPR031148 | |
| Domain | DUF4939 | 3.45e-03 | 10 | 168 | 2 | IPR032549 | |
| Domain | DUF4939 | 3.45e-03 | 10 | 168 | 2 | PF16297 | |
| Domain | ARM-type_fold | 3.65e-03 | 339 | 168 | 9 | IPR016024 | |
| Domain | IQ | 3.84e-03 | 71 | 168 | 4 | PF00612 | |
| Domain | P-loop_NTPase | MYH2 MYH9 MYO5A CENPE MTHFD1L PSMC5 RNF213 ABCA10 MSH6 CLPB MYH14 MYH15 POLQ KIF17 DNAH8 DNAH9 | 4.17e-03 | 848 | 168 | 16 | IPR027417 |
| Domain | Grip | 4.19e-03 | 11 | 168 | 2 | SM00755 | |
| Domain | LDOC1-rel | 4.19e-03 | 11 | 168 | 2 | IPR032567 | |
| Domain | GRIP | 4.19e-03 | 11 | 168 | 2 | PF01465 | |
| Domain | - | 4.19e-03 | 11 | 168 | 2 | 3.40.50.1220 | |
| Domain | GAIN_dom_N | 4.19e-03 | 11 | 168 | 2 | IPR032471 | |
| Domain | GAIN | 4.19e-03 | 11 | 168 | 2 | PF16489 | |
| Domain | EF-hand-dom_pair | 4.52e-03 | 287 | 168 | 8 | IPR011992 | |
| Domain | Ank | 4.64e-03 | 228 | 168 | 7 | PF00023 | |
| Domain | Ran_BP1 | 5.00e-03 | 12 | 168 | 2 | PF00638 | |
| Domain | GrpE_coiled_coil | 5.00e-03 | 12 | 168 | 2 | IPR013805 | |
| Domain | RANBD1 | 5.00e-03 | 12 | 168 | 2 | PS50196 | |
| Domain | GRIP_dom | 5.00e-03 | 12 | 168 | 2 | IPR000237 | |
| Domain | GRIP | 5.00e-03 | 12 | 168 | 2 | PS50913 | |
| Domain | DHS-like_NAD/FAD-binding_dom | 5.00e-03 | 12 | 168 | 2 | IPR029035 | |
| Domain | RanBD | 5.88e-03 | 13 | 168 | 2 | SM00160 | |
| Domain | OLF | 5.88e-03 | 13 | 168 | 2 | PF02191 | |
| Domain | Ran_bind_dom | 5.88e-03 | 13 | 168 | 2 | IPR000156 | |
| Domain | OLF | 5.88e-03 | 13 | 168 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 5.88e-03 | 13 | 168 | 2 | IPR003112 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT23 KRT75 KRT71 | 1.85e-11 | 87 | 128 | 12 | MM15351 |
| Pathway | REACTOME_KERATINIZATION | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT87P KRT73 KRT23 KRT75 KRT71 | 1.39e-08 | 153 | 128 | 12 | MM15343 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT73 KRT23 KRT75 KRT71 | 2.41e-08 | 129 | 128 | 11 | M27649 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ROCK2 PLXNA3 KRT4 MYO5A KRT81 KRT83 KRT85 KRT86 EVPL COL6A5 KRT79 KRT87P KRT73 KRT23 AP2M1 KRT75 KRT71 PLXNA1 | 6.31e-07 | 502 | 128 | 18 | MM14537 |
| Pathway | REACTOME_KERATINIZATION | KRT4 KRT81 KRT83 KRT85 KRT86 EVPL KRT79 KRT73 KRT23 KRT75 KRT71 | 4.49e-06 | 217 | 128 | 11 | M27640 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.29e-05 | 41 | 128 | 5 | MM15200 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.90e-05 | 49 | 128 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 8.72e-05 | 50 | 128 | 5 | MM14610 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 1.99e-04 | 93 | 128 | 6 | M42521 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.83e-04 | 64 | 128 | 5 | M7923 | |
| Pubmed | KRT4 KRT81 KRT83 KRT85 KRT86 KRT79 KRT87P KRT73 KRT23 KRT75 KRT71 | 2.26e-14 | 63 | 178 | 11 | 16831889 | |
| Pubmed | ROCK2 TPR MYH9 AGO2 RGPD8 MYO5A CENPE CENPF SYNE1 HECTD4 RIPK2 SH3BP1 DYRK1A NBEA KEAP1 JAKMIP2 HOOK3 DST SIPA1L1 PDE4DIP MACF1 DIXDC1 SPATS2 PARD3 PPP6R2 TNR | 4.93e-12 | 963 | 178 | 26 | 28671696 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 1.49e-11 | 12 | 178 | 6 | 10692104 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.27e-10 | 16 | 178 | 6 | 12399393 | |
| Pubmed | KDM5B TRAF2 RAP1GDS1 MYO5A KRT83 SYNE1 TSPYL2 HECTD4 DEF8 DYRK1A NBEA TRIM59 RYR3 MIPOL1 AP2M1 P4HTM DST CLPB MYH14 SIPA1L1 PDE4DIP GPSM2 MACF1 AMOTL2 CADPS2 UTRN XPOT | 5.08e-10 | 1285 | 178 | 27 | 35914814 | |
| Pubmed | KRT4 TRAF2 MYH9 AGO2 KRT81 KRT83 KRT85 KRT86 KRT79 KRT73 AP2M1 KRT75 MYH14 | 1.38e-09 | 266 | 178 | 13 | 19380743 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CDC42BPG MYH9 TBC1D30 CENPE CENPF RNF213 EVPL NBEA BIRC6 NUP205 FANCA MIPOL1 MSH6 DST SARS1 BTD AMOTL2 TNR UTRN SYMPK | 1.53e-09 | 736 | 178 | 20 | 29676528 |
| Pubmed | TPR TRAF2 RAP1GDS1 SPTLC1 TRIM59 TBC1D9 MSH6 CEP250 RNF20 RARS2 SRPK3 XPOT NIN | 3.17e-09 | 285 | 178 | 13 | 32838362 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ANKRD35 TRAF2 MYH9 RGPD8 TNIP2 PSMC5 ADGRL1 CCDC88B TBC1D9 SPAG5 MIPOL1 AP2M1 SIPA1L1 GPSM2 ANKRD40 KIF17 ANKS3 | 5.47e-09 | 560 | 178 | 17 | 21653829 |
| Pubmed | ROCK2 PLXNA3 MYH2 MYH9 RGPD8 MYO5A CENPF RBBP8 SYNE1 ANKRD26 KRT79 KRT73 NUP205 KRT23 MIPOL1 AP2M1 DST KRT75 KRT71 MYH14 MACF1 MYH15 CADPS2 POLQ DNAH8 CCDC158 RGPD5 | 5.98e-09 | 1442 | 178 | 27 | 35575683 | |
| Pubmed | KRT4 TRAF2 CCDC146 KRT81 KRT83 PSMC5 LDOC1 KRT79 TRIM59 MIPOL1 FBXL18 PDE4DIP RCOR3 TEKT4 AMOTL2 CCDC158 | 1.11e-08 | 514 | 178 | 16 | 29892012 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.26e-08 | 120 | 178 | 9 | 31413325 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 1.39e-08 | 16 | 178 | 5 | 15085952 | |
| Pubmed | TPR KDM5B MYH9 RGPD8 CENPF RBBP8 ATG2B KEAP1 BIRC6 SPAG5 NEK1 DST RCOR3 UTRN | 3.86e-08 | 418 | 178 | 14 | 34709266 | |
| Pubmed | TPR MYH9 MYO5A CENPF MTHFD1L PSMC5 BIRC6 NUP205 MSH6 DST MYH14 MACF1 UTRN NNT NUP160 XPOT SYMPK | 5.12e-08 | 653 | 178 | 17 | 22586326 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KRT4 MYH2 KDM5B MYH9 MTHFD1L KRT81 KRT85 PSMC5 KEAP1 KRT79 NUP205 CLPB SIPA1L1 PDCD5 MRPL40 SCLT1 PPP6R2 UTRN NUP160 RGPD5 NIN | 5.55e-08 | 1005 | 178 | 21 | 19615732 |
| Pubmed | TPR MYH2 MYH9 CENPF HECTD4 RNF213 NUP205 MYH14 POLQ NUP160 PDZRN3 | 7.68e-08 | 250 | 178 | 11 | 33536335 | |
| Pubmed | 9.30e-08 | 151 | 178 | 9 | 17043677 | ||
| Pubmed | EPN3 TRAF2 HIP1 RAP1GDS1 TNIP2 RIPK2 RNF213 CARD16 KEAP1 BIRC6 FBXO30 EPN2 AP2M1 MRPL40 IKBKB PARD3 | 1.02e-07 | 604 | 178 | 16 | 38803224 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.32e-07 | 3 | 178 | 3 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.32e-07 | 3 | 178 | 3 | 1372089 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 1712823 | ||
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 1.32e-07 | 3 | 178 | 3 | 9084137 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | TRAF2 MYH9 MYO5A MTHFD1L KRT81 ATG2B RNF213 NUP205 AP2M1 SPATS2 UTRN | 1.55e-07 | 268 | 178 | 11 | 33024031 |
| Pubmed | TPR MYO5A RBBP8 KEAP1 SPAG5 MSH6 FBXW8 AP2M1 ATP6V0D1 DST SARS1 RNF20 MACF1 MRPL40 AMOTL2 NNT | 1.96e-07 | 634 | 178 | 16 | 34591612 | |
| Pubmed | HIP1 AGO2 MYO5A HAP1 HECTD4 PSMC5 RNF213 KEAP1 EPN2 AP2M1 DST CLPB MACF1 IKBKB | 2.14e-07 | 481 | 178 | 14 | 28190767 | |
| Pubmed | ROCK2 TBC1D30 ANKRD26 RNF213 BIRC6 TBC1D9 EPN2 NEK1 AP2M1 MACF1 TTC39A PPP6R2 NUP160 PDZRN3 | 2.89e-07 | 493 | 178 | 14 | 15368895 | |
| Pubmed | TPR KRT4 TRAF2 MYH9 EVPL EHBP1L1 DST PDCD5 DEF6 RNF20 MACF1 UTRN | 3.92e-07 | 360 | 178 | 12 | 33111431 | |
| Pubmed | KRT4 MYH2 TRAF2 KRT85 ATG2B SPTLC1 PSMC5 KEAP1 NUP205 SARS1 UTRN ILVBL XPOT | 4.62e-07 | 437 | 178 | 13 | 20562859 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 15797458 | ||
| Pubmed | ANKRD26 BIRC6 MIPOL1 DST SIPA1L1 AMOTL2 PARD3 PPP6R2 UTRN NUP160 FMNL1 ILVBL NIN | 5.81e-07 | 446 | 178 | 13 | 24255178 | |
| Pubmed | MIIP KRT4 TRAF2 HIP1 CCDC146 KRT86 PEX3 RIPK2 PSMC5 LDOC1 KEAP1 KRT79 JAKMIP2 TRIM59 SPAG5 MIPOL1 AP2M1 DEF6 PDE4DIP RNF20 TEKT4 AMOTL2 ANKRD40 VPS29 | 6.01e-07 | 1477 | 178 | 24 | 31515488 | |
| Pubmed | TPR MYO5A SPTLC1 PSMC5 MSH6 SIPA1L1 PDCD5 RNF20 RCOR3 SPATS2 PPP6R2 ILVBL | 1.15e-06 | 399 | 178 | 12 | 37536630 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | ROCK2 KRT4 TRAF2 MYH9 MTHFD1L PSMC5 RNF213 COL6A5 ATAT1 KRT23 MSH6 KRT71 PDE4DIP MRPL46 | 1.25e-06 | 558 | 178 | 14 | 27591049 |
| Pubmed | ROCK2 MYH9 RAP1GDS1 AGO2 MYO5A SYNE1 DYRK1A ADGRL1 NBEA KRT79 EPN2 AP2M1 ATP6V0D1 DST SARS1 MYH14 SIPA1L1 PDE4DIP KNDC1 MACF1 PPP6R2 TNR UTRN | 1.27e-06 | 1431 | 178 | 23 | 37142655 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPN3 MYH9 EPS8L2 EVPL EPS8L1 KEAP1 EPN2 EHBP1L1 DST SSH3 MACF1 PARD3 ADGRL2 UTRN | 1.45e-06 | 565 | 178 | 14 | 25468996 |
| Pubmed | TPR MYH9 RAP1GDS1 SYNE1 LAMA3 ADGRL1 EVPL CCDC88B FBXO30 KRT23 DST CEP250 MACF1 | 1.51e-06 | 486 | 178 | 13 | 20936779 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | TRAF2 RAP1GDS1 CTNNAL1 MTHFD1L ATG2B KEAP1 NUP205 MIPOL1 AP2M1 HOOK3 SARS1 CLPB SSH3 MRPL46 UTRN ILVBL VPS29 XPOT | 1.58e-06 | 931 | 178 | 18 | 27432908 |
| Pubmed | 1.65e-06 | 70 | 178 | 6 | 34255829 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 1.77e-06 | 111 | 178 | 7 | 22558309 | |
| Pubmed | ROCK2 CTNNAL1 SPTLC1 ANKRD26 ADGRL1 EPN2 ATP6V0D1 DST MACF1 PARD3 ADGRL2 UTRN | 2.01e-06 | 421 | 178 | 12 | 36976175 | |
| Pubmed | 2.29e-06 | 284 | 178 | 10 | 29459677 | ||
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 2.42e-06 | 19 | 178 | 4 | 21285247 | |
| Pubmed | 2.42e-06 | 19 | 178 | 4 | 27234308 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 25122462 | ||
| Pubmed | INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. | 2.61e-06 | 6 | 178 | 3 | 15383541 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 30044719 | ||
| Pubmed | 2.68e-06 | 76 | 178 | 6 | 27542412 | ||
| Pubmed | 3.01e-06 | 20 | 178 | 4 | 21689717 | ||
| Pubmed | 4.20e-06 | 304 | 178 | 10 | 32235678 | ||
| Pubmed | TRAF2 AGO2 AOX1 TSPYL2 SPTLC1 RNF213 KEAP1 MSH6 SIPA1L1 MACF1 RCOR3 RARS2 TTC39A PARD3 ADGRL2 PDZRN3 ANKS3 ILVBL NIN | 5.07e-06 | 1116 | 178 | 19 | 31753913 | |
| Pubmed | EPS8L2 CENPF KRT83 KRT85 PSMC5 LZIC FBXO30 SPAG5 KRT73 DST FBXL18 MACF1 | 6.45e-06 | 472 | 178 | 12 | 38943005 | |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 14585990 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYH9 RAP1GDS1 MYO5A CENPF PEX3 KEAP1 TRIM59 MIPOL1 AP2M1 MYH14 CEP250 PDE4DIP SPATS2 NNT NIN | 8.71e-06 | 754 | 178 | 15 | 33060197 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AGO2 CENPE MTHFD1L DYRK1A ANKRD26 SPAG5 NUP205 MIPOL1 HOOK3 SIPA1L1 CEP250 SCLT1 PPP6R2 PDZRN3 VPS29 NIN | 9.00e-06 | 853 | 178 | 16 | 28718761 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TRAF2 RGPD8 CENPE CENPF MTHFD1L SYNE1 PEX3 ATG2B SPTLC1 PSMC5 RNF213 BIRC6 DST SARS1 CLPB PDCD5 RARS2 MRPL40 SPATS2 MRPL46 NNT NUP160 | 9.03e-06 | 1496 | 178 | 22 | 32877691 |
| Pubmed | 1.06e-05 | 27 | 178 | 4 | 18685082 | ||
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 27387502 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ROCK2 TRPC4AP CTNNAL1 MTHFD1L AZU1 PSMC5 EVPL NUP205 MSH6 AP2M1 CLPB ADGRL2 PPP6R2 UTRN NUP160 VPS29 XPOT | 1.19e-05 | 974 | 178 | 17 | 28675297 |
| Pubmed | ROCK2 TRAF2 MYH9 EPS8L2 MTHFD1L SPTLC1 PSMC5 KEAP1 BIRC6 AP2M1 P4HTM ATP6V0D1 DST PDCD5 MACF1 MRPL40 IKBKB NUP160 ILVBL XPOT | 1.21e-05 | 1297 | 178 | 20 | 33545068 | |
| Pubmed | 1.32e-05 | 209 | 178 | 8 | 36779422 | ||
| Pubmed | HIP1 AGO2 HAP1 MTHFD1L ADGRL1 SIPA1L1 CEP250 MACF1 SPATS2 PARD3 TNR | 1.49e-05 | 430 | 178 | 11 | 32581705 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | CDC42BPG TRAF2 MYH9 AGO2 MYO5A TNIP2 KRT86 RIPK2 MYH14 IKBKB | 1.54e-05 | 353 | 178 | 10 | 27545878 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 PLXNA3 HIP1 MTHFD1L TSNARE1 HECTD4 DYRK1A ADGRL1 BIRC6 TBC1D9 FANCA EHBP1L1 DST DEF6 PLA2G6 MRPL46 PLXNA1 SYMPK | 1.64e-05 | 1105 | 178 | 18 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANKRD35 CENPE TNIP2 EPS8L1 CCDC88B MIPOL1 MACF1 CADPS2 DNAH9 FMNL1 | 1.87e-05 | 361 | 178 | 10 | 26167880 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.96e-05 | 363 | 178 | 10 | 14691545 | |
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | 2.00e-05 | 364 | 178 | 10 | 31391242 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR TRAF2 MYH9 AGO2 MYO5A MTHFD1L PSMC5 BIRC6 NUP205 MSH6 AP2M1 DST FBXL18 MYH14 RNF20 MACF1 PARD3 UTRN NUP160 XPOT | 2.21e-05 | 1353 | 178 | 20 | 29467282 |
| Pubmed | 2.22e-05 | 163 | 178 | 7 | 16512683 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TRAF2 MYH9 TRPC4AP CTNNAL1 MYO5A MTHFD1L KRT81 KRT83 PEX3 ADCY2 DPH6 EHBP1L1 MYH14 CEP250 DEF6 PLA2G6 RARS2 IKBKB SYMPK | 2.25e-05 | 1242 | 178 | 19 | 30973865 |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 2.52e-05 | 112 | 178 | 6 | 20473970 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 11002341 | ||
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 2.60e-05 | 2 | 178 | 2 | 15744029 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16876162 | ||
| Pubmed | Two human genes related to murine vanin-1 are located on the long arm of human chromosome 6. | 2.60e-05 | 2 | 178 | 2 | 9790769 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 20600852 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 29545013 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17383637 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 9665406 | ||
| Pubmed | Myosin-IIA and ICAM-1 regulate the interchange between two distinct modes of T cell migration. | 2.60e-05 | 2 | 178 | 2 | 19201857 | |
| Pubmed | Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network. | 2.60e-05 | 2 | 178 | 2 | 30209081 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 25926686 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24675808 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 9402962 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 9506584 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19592499 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16354923 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 27134178 | ||
| Pubmed | Role for formin-like 1-dependent acto-myosin assembly in lipid droplet dynamics and lipid storage. | 2.60e-05 | 2 | 178 | 2 | 28361956 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 15784680 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 32889079 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 34374341 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 7851898 | ||
| Pubmed | Par3 controls epithelial spindle orientation by aPKC-mediated phosphorylation of apical Pins. | 2.60e-05 | 2 | 178 | 2 | 20933426 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21895414 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 2.65e-05 | 113 | 178 | 6 | 34474245 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR MYH9 ATG2B ANKRD26 PSMC5 KEAP1 LZIC SPAG5 MSH6 NEK1 AP2M1 DST PDCD5 MACF1 PPP6R2 UTRN | 2.72e-05 | 934 | 178 | 16 | 33916271 |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 2.73e-05 | 34 | 178 | 4 | 25925205 | |
| Pubmed | 2.80e-05 | 12 | 178 | 3 | 22031545 | ||
| Pubmed | 2.98e-05 | 234 | 178 | 8 | 36243803 | ||
| Interaction | KRT27 interactions | KRT4 CCDC146 KRT81 KRT83 TNIP2 KRT85 KRT86 PSMC5 LMNTD2 KRT79 CCDC88B SPAG5 HOOK3 KRT75 KRT71 CEP250 RCOR3 | 2.71e-12 | 202 | 177 | 17 | int:KRT27 |
| Interaction | KRT25 interactions | 1.47e-11 | 35 | 177 | 9 | int:KRT25 | |
| Interaction | KRT19 interactions | KRT4 CCDC146 KRT81 KRT83 TNIP2 KRT85 KRT86 ANKRD26 KRT79 BIRC6 SPAG5 KRT73 HOOK3 KRT75 KRT71 RCOR3 AMOTL2 NIN | 6.22e-11 | 282 | 177 | 18 | int:KRT19 |
| Interaction | RALBP1 interactions | EPN3 CDC42BPG TRAF2 DYRK1A ANKRD26 PSMC5 LDOC1 CCDC88B BIRC6 EPN2 AP2M1 HOOK3 SRGAP1 CEP250 AMOTL2 | 2.44e-10 | 198 | 177 | 15 | int:RALBP1 |
| Interaction | KRT38 interactions | KRT4 CCDC146 KRT81 KRT83 KRT85 KRT86 PSMC5 KRT79 SPAG5 KRT75 KRT71 AMOTL2 CCDC40 NIN | 3.84e-10 | 172 | 177 | 14 | int:KRT38 |
| Interaction | KRT31 interactions | KRT4 CCDC146 KRT81 KRT83 TNIP2 KRT85 KRT86 PSMC5 LMNTD2 KRT79 BIRC6 KRT73 HOOK3 KRT75 KRT71 DEF6 PDE4DIP RCOR3 MRPL40 AMOTL2 CCDC17 | 5.59e-10 | 453 | 177 | 21 | int:KRT31 |
| Interaction | KRT15 interactions | KRT4 KRT81 KRT83 KRT85 KRT86 PSMC5 LDOC1 KRT79 KRT73 KRT75 KRT71 RCOR3 TEKT4 AMOTL2 | 6.04e-10 | 178 | 177 | 14 | int:KRT15 |
| Interaction | KRT36 interactions | 1.72e-08 | 74 | 177 | 9 | int:KRT36 | |
| Interaction | KRT37 interactions | 1.85e-08 | 100 | 177 | 10 | int:KRT37 | |
| Interaction | KRT26 interactions | 1.96e-08 | 35 | 177 | 7 | int:KRT26 | |
| Interaction | KRT18 interactions | KRT4 CCDC146 KRT81 ANKRD26 LDOC1 KRT79 BIRC6 SPAG5 KRT73 NUP205 KRT75 KRT71 PDE4DIP RCOR3 TEKT4 NUP160 PDZRN3 NIN | 3.30e-08 | 419 | 177 | 18 | int:KRT18 |
| Interaction | KRT35 interactions | KRT4 TBC1D30 KRT81 KRT83 KRT85 KRT86 KRT79 KRT75 KRT71 TEKT4 | 5.08e-08 | 111 | 177 | 10 | int:KRT35 |
| Interaction | EPS15 interactions | EPN3 KRT4 TRAF2 MYH9 KRT83 KRT85 KRT86 DYRK1A KRT79 EPN2 KRT73 AP2M1 KRT75 | 7.77e-08 | 220 | 177 | 13 | int:EPS15 |
| Interaction | NUP62 interactions | TPR RGPD8 CCDC146 TNIP2 NUP205 KRT75 CEP250 RNF20 SPATS2 AMOTL2 NUP160 XPOT RGPD5 NIN | 1.41e-07 | 273 | 177 | 14 | int:NUP62 |
| Interaction | KRT16 interactions | KRT4 CCDC146 KRT81 KRT83 KRT85 KRT86 KRT79 KRT73 AP2M1 KRT75 KRT71 CCDC17 | 1.80e-07 | 197 | 177 | 12 | int:KRT16 |
| Interaction | KRT34 interactions | MIIP KRT4 CCDC146 KRT81 KRT83 TNIP2 KRT85 KRT86 KRT79 KRT73 HOOK3 KRT75 KRT71 TEKT4 | 2.18e-07 | 283 | 177 | 14 | int:KRT34 |
| Interaction | KRT24 interactions | 4.48e-07 | 54 | 177 | 7 | int:KRT24 | |
| Interaction | WHAMMP3 interactions | 1.07e-06 | 119 | 177 | 9 | int:WHAMMP3 | |
| Interaction | SASS6 interactions | RGPD8 CENPE KRT83 TNIP2 ANKRD26 KEAP1 SPAG5 SIPA1L1 CEP250 NIN | 1.46e-06 | 159 | 177 | 10 | int:SASS6 |
| Interaction | PCM1 interactions | CENPE HAP1 KRT81 KRT83 KRT86 ANKRD26 SPAG5 KRT73 HOOK3 SRGAP1 CEP250 SPATS2 SCLT1 PDZRN3 CCDC40 NIN | 1.51e-06 | 434 | 177 | 16 | int:PCM1 |
| Interaction | KRT33B interactions | 1.63e-06 | 93 | 177 | 8 | int:KRT33B | |
| Interaction | KRT8 interactions | MYH9 TNIP2 ANKRD26 KRT79 BIRC6 SPAG5 KRT73 NUP205 KRT23 KRT75 KRT71 SIPA1L1 PPP6R2 PDZRN3 XPOT NIN | 1.86e-06 | 441 | 177 | 16 | int:KRT8 |
| Interaction | LURAP1 interactions | 3.47e-06 | 137 | 177 | 9 | int:LURAP1 | |
| Interaction | KRT28 interactions | 5.89e-06 | 30 | 177 | 5 | int:KRT28 | |
| Interaction | TBKBP1 interactions | 6.63e-06 | 80 | 177 | 7 | int:TBKBP1 | |
| Interaction | KRT40 interactions | KRT4 MYH2 CCDC146 KRT81 KRT83 KRT85 KRT86 PSMC5 RNF213 KRT79 KRT73 FBXL18 KRT75 KRT71 RCOR3 | 7.08e-06 | 434 | 177 | 15 | int:KRT40 |
| Interaction | KRT14 interactions | 7.90e-06 | 192 | 177 | 10 | int:KRT14 | |
| Interaction | KRT13 interactions | 8.57e-06 | 116 | 177 | 8 | int:KRT13 | |
| Interaction | APC interactions | TPR SYNE1 LAMA3 ADGRL1 FBXO30 SPAG5 KRT23 AP2M1 HOOK3 DST CEP250 MACF1 PARD3 NIN | 9.18e-06 | 389 | 177 | 14 | int:APC |
| Interaction | SIPA1L3 interactions | 9.72e-06 | 118 | 177 | 8 | int:SIPA1L3 | |
| Interaction | DYNLL1 interactions | TPR CDC42BPG MYH9 MYO5A TNIP2 TSNARE1 SPTLC1 DYRK1A COP1 FBXO30 SPAG5 PDE4DIP RCOR3 AMOTL2 PARD3 PDZRN3 | 1.17e-05 | 510 | 177 | 16 | int:DYNLL1 |
| Interaction | YWHAQ interactions | MIIP TPR MYH2 KDM5B MYH9 HECTD4 RIPK2 DYRK1A ANKRD26 ATAT1 TRIM59 EPN2 NEK1 FBXW8 HOOK3 DST CLPB SRGAP1 SIPA1L1 CEP250 RNF20 MACF1 RCOR3 AMOTL2 PARD3 | 1.59e-05 | 1118 | 177 | 25 | int:YWHAQ |
| Interaction | SYCE3 interactions | 1.89e-05 | 63 | 177 | 6 | int:SYCE3 | |
| Interaction | INSYN1 interactions | 1.90e-05 | 169 | 177 | 9 | int:INSYN1 | |
| Interaction | KXD1 interactions | 1.99e-05 | 170 | 177 | 9 | int:KXD1 | |
| Interaction | RAC1 interactions | ROCK2 CDC42BPG MYH9 HIP1 RAP1GDS1 CTNNAL1 SPTLC1 SH3BP1 ANKRD26 ADGRL1 NUP205 EHBP1L1 AP2M1 DST SRGAP1 DEF6 MACF1 PARD3 ADGRL2 UTRN NUP160 FMNL1 PLXNA1 XPOT | 2.05e-05 | 1063 | 177 | 24 | int:RAC1 |
| Interaction | DSCAM interactions | 2.09e-05 | 171 | 177 | 9 | int:DSCAM | |
| Interaction | DYNLL2 interactions | CDC42BPG MYO5A DYRK1A FBXO30 SPAG5 NEK1 MYH14 PDE4DIP RCOR3 AMOTL2 PDZRN3 | 2.19e-05 | 263 | 177 | 11 | int:DYNLL2 |
| Interaction | CASQ2 interactions | 2.70e-05 | 67 | 177 | 6 | int:CASQ2 | |
| Interaction | RNF123 interactions | CDC42BPG MYH9 TBC1D30 CENPE CENPF RNF213 EVPL NBEA BIRC6 NUP205 FANCA MIPOL1 MSH6 DST SARS1 BTD AMOTL2 TNR UTRN SYMPK | 3.92e-05 | 824 | 177 | 20 | int:RNF123 |
| Interaction | PHF21A interactions | TPR CENPF RBBP8 ATG2B KEAP1 BIRC6 SPAG5 NEK1 DST RCOR3 SCLT1 UTRN | 5.34e-05 | 343 | 177 | 12 | int:PHF21A |
| Interaction | KRT5 interactions | 5.39e-05 | 193 | 177 | 9 | int:KRT5 | |
| Interaction | ATOH1 interactions | 7.40e-05 | 80 | 177 | 6 | int:ATOH1 | |
| Interaction | AIRIM interactions | 8.30e-05 | 159 | 177 | 8 | int:AIRIM | |
| Interaction | ZNF688 interactions | 8.32e-05 | 118 | 177 | 7 | int:ZNF688 | |
| Interaction | CCDC146 interactions | 8.50e-05 | 82 | 177 | 6 | int:CCDC146 | |
| Interaction | DTNBP1 interactions | 9.46e-05 | 162 | 177 | 8 | int:DTNBP1 | |
| Interaction | NDC80 interactions | ROCK2 CENPE ANKRD26 COP1 BIRC6 SPAG5 KRT75 CEP250 AMOTL2 SCLT1 NIN | 1.03e-04 | 312 | 177 | 11 | int:NDC80 |
| Interaction | AMOT interactions | TNIP2 ANKRD26 BIRC6 SPAG5 KRT75 SIPA1L1 CEP250 AMOTL2 PARD3 SCLT1 NIN | 1.03e-04 | 312 | 177 | 11 | int:AMOT |
| Interaction | PEX5L interactions | 1.10e-04 | 54 | 177 | 5 | int:PEX5L | |
| Interaction | RCOR1 interactions | TPR KDM5B MYH9 CENPF RBBP8 ATG2B KEAP1 BIRC6 MSH6 NEK1 DST RCOR3 SCLT1 UTRN | 1.23e-04 | 494 | 177 | 14 | int:RCOR1 |
| Interaction | TNIK interactions | TPR TRAF2 MYO5A CENPF SYNE1 NBEA DST SIPA1L1 PDE4DIP MACF1 IKBKB TNR | 1.44e-04 | 381 | 177 | 12 | int:TNIK |
| Interaction | NUP107 interactions | 1.52e-04 | 221 | 177 | 9 | int:NUP107 | |
| Interaction | CDK18 interactions | 1.60e-04 | 131 | 177 | 7 | int:CDK18 | |
| Interaction | UBC interactions | MYH9 HIP1 MYO5A HAP1 HECTD4 PSMC5 RNF213 KEAP1 EPN2 AP2M1 DST CLPB IKBKB | 1.64e-04 | 446 | 177 | 13 | int:UBC |
| Interaction | TBC1D7 interactions | 1.82e-04 | 60 | 177 | 5 | int:TBC1D7 | |
| Interaction | CEP63 interactions | 1.88e-04 | 179 | 177 | 8 | int:CEP63 | |
| Interaction | SIPA1L2 interactions | 2.02e-04 | 136 | 177 | 7 | int:SIPA1L2 | |
| Interaction | KRT75 interactions | 2.03e-04 | 181 | 177 | 8 | int:KRT75 | |
| Interaction | NINL interactions | AGO2 MYO5A CENPE CCDC146 TNIP2 DYRK1A ANKRD26 SPAG5 MIPOL1 SIPA1L1 CEP250 RCOR3 SCLT1 | 2.13e-04 | 458 | 177 | 13 | int:NINL |
| Interaction | CYLD interactions | ROCK2 KRT4 TRAF2 MYH9 MTHFD1L RIPK2 DYRK1A PSMC5 RNF213 COL6A5 ATAT1 KRT23 MSH6 AP2M1 KRT71 PDE4DIP MRPL46 PARD3 NIN | 2.35e-04 | 868 | 177 | 19 | int:CYLD |
| Interaction | KDM1A interactions | TPR KDM5B MYH9 CENPF RBBP8 ATG2B KEAP1 BIRC6 SPAG5 MSH6 NEK1 AP2M1 DST PDCD5 PDE4DIP RCOR3 SCLT1 UTRN SYMPK NIN | 2.36e-04 | 941 | 177 | 20 | int:KDM1A |
| Interaction | ATG5 interactions | HIP1 MYO5A MTHFD1L ATG2B RNF213 KEAP1 AP2M1 HOOK3 ATP6V0D1 TEKT4 UTRN | 2.40e-04 | 344 | 177 | 11 | int:ATG5 |
| Interaction | TSGA10IP interactions | 2.41e-04 | 140 | 177 | 7 | int:TSGA10IP | |
| Interaction | TXLNA interactions | 2.48e-04 | 236 | 177 | 9 | int:TXLNA | |
| Interaction | DUSP16 interactions | 2.55e-04 | 237 | 177 | 9 | int:DUSP16 | |
| Interaction | SEPTIN10 interactions | 2.86e-04 | 144 | 177 | 7 | int:SEPTIN10 | |
| Interaction | RHOF interactions | ROCK2 HIP1 RAP1GDS1 MYO5A ANKRD26 ADGRL1 NUP205 EHBP1L1 MACF1 RARS2 PARD3 ADGRL2 UTRN FMNL1 PLXNA1 XPOT | 3.03e-04 | 673 | 177 | 16 | int:RHOF |
| Interaction | SIRT7 interactions | TPR MYH9 MYO5A CENPF MTHFD1L PSMC5 BIRC6 NUP205 MSH6 DST MYH14 MACF1 UTRN NNT NUP160 XPOT SYMPK | 3.10e-04 | 744 | 177 | 17 | int:SIRT7 |
| Interaction | DSCR9 interactions | 3.25e-04 | 147 | 177 | 7 | int:DSCR9 | |
| Interaction | FAM50B interactions | 3.52e-04 | 69 | 177 | 5 | int:FAM50B | |
| Interaction | FBXO25 interactions | 3.73e-04 | 198 | 177 | 8 | int:FBXO25 | |
| Interaction | MOB3C interactions | TPR SPTLC1 PSMC5 MSH6 SIPA1L1 PDCD5 RNF20 RCOR3 SPATS2 PPP6R2 ILVBL | 3.88e-04 | 364 | 177 | 11 | int:MOB3C |
| Interaction | TSKS interactions | 4.11e-04 | 40 | 177 | 4 | int:TSKS | |
| Interaction | GAN interactions | 4.12e-04 | 253 | 177 | 9 | int:GAN | |
| Interaction | RHOB interactions | ROCK2 HIP1 RAP1GDS1 SPTLC1 ANKRD26 ADGRL1 NBEA EPN2 NUP205 AP2M1 SIPA1L1 MACF1 PARD3 ADGRL2 UTRN NUP160 FMNL1 PLXNA1 | 4.45e-04 | 840 | 177 | 18 | int:RHOB |
| Interaction | TMEM178B interactions | 4.55e-04 | 4 | 177 | 2 | int:TMEM178B | |
| Interaction | SPAG5-AS1 interactions | 4.55e-04 | 4 | 177 | 2 | int:SPAG5-AS1 | |
| Interaction | SHANK3 interactions | ROCK2 ANKRD35 MYO5A SYNE1 TNIP2 ADGRL1 SPAG5 DPH6 MIPOL1 ATP6V0D1 MACF1 PPP6R2 TNR | 4.56e-04 | 496 | 177 | 13 | int:SHANK3 |
| Interaction | LPIN3 interactions | 4.58e-04 | 73 | 177 | 5 | int:LPIN3 | |
| Interaction | DCTN1 interactions | TPR CENPE HAP1 TNIP2 SPAG5 MSH6 HOOK3 DST KRT75 MACF1 NNT VPS29 NIN | 4.65e-04 | 497 | 177 | 13 | int:DCTN1 |
| Interaction | HOXB5 interactions | 4.67e-04 | 112 | 177 | 6 | int:HOXB5 | |
| Interaction | CEP170P1 interactions | 4.90e-04 | 113 | 177 | 6 | int:CEP170P1 | |
| Interaction | MLF1 interactions | 4.90e-04 | 113 | 177 | 6 | int:MLF1 | |
| Interaction | NHLRC2 interactions | KRT85 KRT86 KEAP1 KRT79 KRT73 KRT23 SARS1 DEF6 MACF1 SCLT1 FMNL1 | 4.98e-04 | 375 | 177 | 11 | int:NHLRC2 |
| Interaction | SLFN11 interactions | TPR MYH2 MYH9 CENPF HECTD4 RNF213 NUP205 MYH14 POLQ NUP160 PDZRN3 | 5.09e-04 | 376 | 177 | 11 | int:SLFN11 |
| Interaction | DIRAS3 interactions | 5.31e-04 | 262 | 177 | 9 | int:DIRAS3 | |
| Interaction | KRT6A interactions | 5.41e-04 | 160 | 177 | 7 | int:KRT6A | |
| Interaction | CFAP184 interactions | 5.82e-04 | 162 | 177 | 7 | int:CFAP184 | |
| Cytoband | 12q13 | 3.63e-07 | 71 | 178 | 6 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | KRT4 KRT81 KRT83 KRT85 KRT86 KRT79 KRT87P KRT73 KRT75 KRT71 SPATS2 | 9.37e-07 | 423 | 178 | 11 | chr12q13 |
| Cytoband | 6q24 | 4.12e-04 | 8 | 178 | 2 | 6q24 | |
| Cytoband | 6q23-q24 | 5.29e-04 | 9 | 178 | 2 | 6q23-q24 | |
| GeneFamily | Keratins, type II | 3.22e-14 | 27 | 109 | 9 | 609 | |
| GeneFamily | Myosin heavy chains | 1.62e-06 | 15 | 109 | 4 | 1098 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.17e-05 | 8 | 109 | 3 | 939 | |
| GeneFamily | Vanins | 1.08e-04 | 3 | 109 | 2 | 10 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 2.14e-04 | 4 | 109 | 2 | 918 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.59e-04 | 115 | 109 | 5 | 769 | |
| GeneFamily | Ankyrin repeat domain containing | 6.61e-04 | 242 | 109 | 7 | 403 | |
| GeneFamily | Nucleoporins | 9.31e-04 | 32 | 109 | 3 | 1051 | |
| GeneFamily | Plexins | 1.26e-03 | 9 | 109 | 2 | 683 | |
| GeneFamily | Dyneins, axonemal | 4.62e-03 | 17 | 109 | 2 | 536 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.42e-05 | 173 | 177 | 8 | M650 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | AGO2 ZSWIM3 CENPE CENPF DYRK1A TRIM59 CCDC7 MIPOL1 MSH6 NEK1 EHBP1L1 HOOK3 DST GPSM2 MACF1 CADPS2 POLQ NIN | 3.67e-05 | 892 | 177 | 18 | M18120 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPR KDM5B CTNNAL1 RBBP8 KRT81 KRT83 KRT85 KRT86 KRT79 KRT23 KRT75 CLPB KRT71 MYH14 PDE4DIP | 3.78e-05 | 650 | 177 | 15 | MM1042 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ROCK2 TPR TGIF2 TRPC4AP AGO2 COP1 ZBTB12 SPAG5 NUP205 FBXW8 RNF20 RCOR3 UTRN | 5.55e-05 | 519 | 177 | 13 | M3395 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP | 6.53e-05 | 199 | 177 | 8 | M9419 | |
| Coexpression | GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP | 6.53e-05 | 199 | 177 | 8 | M8761 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP | EPN3 PLXNA3 TBC1D30 COP1 EPS8L1 KRT23 P4HTM MYH14 SSH3 TTC39A CADPS2 SYMPK | 6.62e-05 | 455 | 177 | 12 | M17299 |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN | 6.77e-05 | 200 | 177 | 8 | M9303 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN | 6.77e-05 | 200 | 177 | 8 | M4832 | |
| Coexpression | GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN | 6.77e-05 | 200 | 177 | 8 | M7799 | |
| Coexpression | GSE6875_TCONV_VS_FOXP3_KO_TREG_DN | 6.77e-05 | 200 | 177 | 8 | M6802 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPR KDM5B CTNNAL1 RBBP8 KRT81 KRT83 KRT85 KRT86 KRT79 KRT23 KRT75 KRT71 MYH14 PDE4DIP | 7.32e-05 | 610 | 177 | 14 | M3854 |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 7.77e-05 | 204 | 177 | 8 | MM966 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ROCK2 TPR TGIF2 TRPC4AP AGO2 COP1 ZBTB12 SPAG5 NUP205 FBXW8 RNF20 RCOR3 UTRN | 8.74e-05 | 543 | 177 | 13 | MM997 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.02e-04 | 212 | 177 | 8 | M39221 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TPR NIBAN1 RAP1GDS1 AGO2 CENPE RBBP8 SYNE1 PEX3 ANKRD26 RNF213 NBEA FBXO30 FANCA MSH6 DEF6 MACF1 DIXDC1 TRPM1 FMNL1 PDZRN3 ILVBL | 5.02e-06 | 834 | 174 | 21 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 HIP1 CENPE CENPF RBBP8 ANKRD26 PSMC5 ZBTB12 JAKMIP2 BIRC6 FBXO30 SPAG5 MSH6 POLQ SCLT1 CCDC40 | 8.36e-06 | 532 | 174 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ROCK2 RAP1GDS1 CENPE CENPF RBBP8 FBXO30 DMXL1 MSH6 DST MYH14 PARD3 SCLT1 CCDC40 NAA16 | 3.40e-05 | 469 | 174 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TPR NIBAN1 RAP1GDS1 AGO2 CENPE RBBP8 PEX3 ANKRD26 RNF213 KEAP1 JAKMIP2 ADCY2 FBXO30 FANCA MSH6 MYH14 KNDC1 MACF1 DIXDC1 TRPM1 FMNL1 | 5.35e-05 | 978 | 174 | 21 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ROCK2 MYO5A CENPE CENPF ANKRD26 ZBTB12 JAKMIP2 SPAG5 NEK1 SRGAP1 POLQ | 5.40e-05 | 311 | 174 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | e10.5_NeuroEpith_FlankLateral_top-relative-expression-ranked_500_5 | RAP1GDS1 MTHFD1L RIPK2 SH3BP1 FBXW8 INTS15 DIXDC1 IKBKB NUP160 XPOT NAA16 | 9.17e-05 | 330 | 174 | 11 | Facebase_ST1_e10.5_NeuroEpith_FlankLateral_500_5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | TPR NIBAN1 RAP1GDS1 AGO2 PEX3 RNF213 KEAP1 FANCA DIXDC1 TRPM1 FMNL1 | 9.41e-05 | 331 | 174 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | AGO2 CENPE CENPF HAP1 PEX3 SGPP2 ANKRD26 KEAP1 JAKMIP2 LZIC FANCA SRGAP1 PDCD5 MACF1 DIXDC1 IKBKB CCDC171 ANKRD40 UTRN NIN | 1.72e-04 | 985 | 174 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.82e-04 | 298 | 174 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.90e-04 | 192 | 174 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.02e-04 | 246 | 174 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TPR AGO2 CENPE RBBP8 PEX3 ANKRD26 KEAP1 JAKMIP2 MSH6 KNDC1 MACF1 DIXDC1 TRPM1 | 2.18e-04 | 492 | 174 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 TPR CENPE SYNE1 DYRK1A RNF213 FANCA MACF1 DIXDC1 TRPM1 SCLT1 FMNL1 | 2.43e-04 | 432 | 174 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.64e-04 | 255 | 174 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_500 | RAP1GDS1 MTHFD1L RIPK2 SH3BP1 LZIC FBXW8 INTS15 DIXDC1 IKBKB NUP160 XPOT NAA16 | 2.81e-04 | 439 | 174 | 12 | Facebase_ST1_e9.5_MaxilArch_500 |
| ToppCell | Ciliated-cil-3|World / Class top | 8.02e-08 | 192 | 177 | 9 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.16e-08 | 195 | 177 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.16e-08 | 195 | 177 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-07 | 199 | 177 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.43e-07 | 180 | 177 | 8 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 8.92e-07 | 188 | 177 | 8 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-07 | 189 | 177 | 8 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-07 | 189 | 177 | 8 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-07 | 189 | 177 | 8 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-06 | 191 | 177 | 8 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-06 | 191 | 177 | 8 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-06 | 194 | 177 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 1.27e-06 | 197 | 177 | 8 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 197 | 177 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-06 | 198 | 177 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 177 | 8 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 177 | 8 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 169 | 177 | 7 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 6.56e-06 | 175 | 177 | 7 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 176 | 177 | 7 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 177 | 177 | 7 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 178 | 177 | 7 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 7.33e-06 | 178 | 177 | 7 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.33e-06 | 178 | 177 | 7 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 178 | 177 | 7 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-06 | 179 | 177 | 7 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-06 | 179 | 177 | 7 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-06 | 180 | 177 | 7 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-06 | 180 | 177 | 7 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-06 | 180 | 177 | 7 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-06 | 184 | 177 | 7 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-06 | 184 | 177 | 7 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.43e-06 | 185 | 177 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 187 | 177 | 7 | 269145d71576cbe8fa217090c8aac82d915dbc04 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 187 | 177 | 7 | 7a50aded3243bef2075fb3ec550939ce0694919a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 187 | 177 | 7 | 629b3e05840eb10e598b8dfaabd92ebe02f9995a | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.05e-05 | 188 | 177 | 7 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 188 | 177 | 7 | c2ef270f691d367b1621d48f0771267cefe1630d | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-05 | 189 | 177 | 7 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 1.08e-05 | 189 | 177 | 7 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.08e-05 | 189 | 177 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 189 | 177 | 7 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 190 | 177 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 190 | 177 | 7 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 191 | 177 | 7 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 191 | 177 | 7 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | b55500eb416f4f339031acad16b2737e5b891d8e | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 191 | 177 | 7 | 8688708c9183ebcb200596501dc30cc12073f151 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 192 | 177 | 7 | bb7eb51bc079acacde42d8e55ba06d03eba2ea28 | |
| ToppCell | facs-Lung-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 192 | 177 | 7 | ebfd8209a7353fbccb8ca7ade14b4f25822cebd2 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 192 | 177 | 7 | a50a6279371b3be682e334082637b7ab76b9a6e5 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.24e-05 | 193 | 177 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.24e-05 | 193 | 177 | 7 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 194 | 177 | 7 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 194 | 177 | 7 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 1.33e-05 | 195 | 177 | 7 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.33e-05 | 195 | 177 | 7 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.37e-05 | 196 | 177 | 7 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.42e-05 | 197 | 177 | 7 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-05 | 197 | 177 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-05 | 197 | 177 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-05 | 197 | 177 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-05 | 197 | 177 | 7 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-05 | 197 | 177 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-05 | 197 | 177 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-05 | 197 | 177 | 7 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 198 | 177 | 7 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-05 | 198 | 177 | 7 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-05 | 198 | 177 | 7 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 198 | 177 | 7 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-05 | 198 | 177 | 7 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-05 | 198 | 177 | 7 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 199 | 177 | 7 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.51e-05 | 199 | 177 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 1.51e-05 | 199 | 177 | 7 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 199 | 177 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 199 | 177 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | severe-T/NK_proliferative|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 177 | 7 | 9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| Computational | Intermediate filaments and MT. | 7.99e-05 | 68 | 114 | 6 | MODULE_438 | |
| Drug | homocysteine thiolactone | KRT4 KRT81 KRT83 KRT85 KRT86 KRT73 KRT23 SARS1 KRT75 KRT71 DNAH9 | 6.12e-09 | 131 | 176 | 11 | CID000107712 |
| Drug | teleocidin B | 4.16e-08 | 123 | 176 | 10 | CID000072425 | |
| Drug | AC1L9MJT | 3.14e-07 | 192 | 176 | 11 | CID000448959 | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | MIIP TRAF2 HIP1 TBC1D30 PEX3 SPTLC1 ANKRD26 BTD SIPA1L1 PLA2G6 CD180 | 3.67e-07 | 195 | 176 | 11 | 3135_DN |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | MIIP ANKRD26 EPS8L1 EHBP1L1 SSH3 PDE4DIP PLA2G6 CD180 NUP160 PLXNA1 SYMPK | 3.86e-07 | 196 | 176 | 11 | 2936_DN |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | KRT4 HIP1 MANBA TBC1D30 CENPF EPS8L1 FANCA DEF6 PPP6R2 ANKRD40 NUP160 | 3.86e-07 | 196 | 176 | 11 | 4494_DN |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A | KRT4 HIP1 MANBA SPTLC1 FANCA BTD SSH3 PPP6R2 UTRN NNT NUP160 | 4.49e-07 | 199 | 176 | 11 | 7284_DN |
| Drug | al-Badry | 6.56e-07 | 165 | 176 | 10 | CID000004545 | |
| Drug | sulfur mustard | 7.93e-07 | 130 | 176 | 9 | CID000010461 | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; HL60; HT_HG-U133A | 2.98e-06 | 195 | 176 | 10 | 2568_DN | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A | 3.42e-06 | 198 | 176 | 10 | 1913_DN | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | TRAF2 TSPYL2 ADGRL1 EPS8L1 NEK1 CEP250 PDE4DIP MACF1 NNT NUP160 | 3.42e-06 | 198 | 176 | 10 | 7416_DN |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | PLXNA3 MYH9 EPS8L1 NEK1 EHBP1L1 BTD SSH3 PARD3 PDZRN3 PLXNA1 | 3.42e-06 | 198 | 176 | 10 | 2809_DN |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.74e-06 | 200 | 176 | 10 | 6484_DN | |
| Drug | purealin | 5.68e-06 | 58 | 176 | 6 | CID006419303 | |
| Drug | k012 | 5.68e-06 | 58 | 176 | 6 | CID000000988 | |
| Drug | hexamethylmelamine | 1.46e-05 | 102 | 176 | 7 | CID000002123 | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.57e-05 | 187 | 176 | 9 | 1656_DN | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.93e-05 | 192 | 176 | 9 | 6714_DN | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | 2.01e-05 | 193 | 176 | 9 | 2505_DN | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 2.10e-05 | 194 | 176 | 9 | 1211_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.10e-05 | 194 | 176 | 9 | 5932_DN | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.19e-05 | 195 | 176 | 9 | 6285_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 4769_DN | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 7321_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 3515_DN | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; HL60; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2143_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 7235_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 5246_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; HL60; HT_HG-U133A | 2.67e-05 | 200 | 176 | 9 | 2134_DN | |
| Drug | B0683 | 3.55e-05 | 117 | 176 | 7 | CID006398969 | |
| Drug | Velcade (bortezomib | KRT4 TRAF2 KRT81 KRT83 KRT85 KRT86 CARD16 KRT73 KRT23 KRT75 KRT71 IKBKB | 3.64e-05 | 374 | 176 | 12 | CID000093860 |
| Drug | plakin | 4.22e-05 | 82 | 176 | 6 | CID000018752 | |
| Drug | formycin triphosphate | 4.59e-05 | 51 | 176 | 5 | CID000122274 | |
| Drug | melicopicine | 5.94e-05 | 2 | 176 | 2 | CID000101253 | |
| Drug | tebuquine | 5.94e-05 | 2 | 176 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 5.94e-05 | 2 | 176 | 2 | CID000460896 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 6.48e-05 | 174 | 176 | 8 | 7530_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 8.87e-05 | 182 | 176 | 8 | 1663_DN | |
| Drug | trioxane | 1.23e-04 | 13 | 176 | 3 | CID000008081 | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.33e-04 | 193 | 176 | 8 | 7232_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 2524_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 176 | 8 | 1707_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 6643_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 6259_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A | 1.43e-04 | 195 | 176 | 8 | 1984_DN | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A | 1.43e-04 | 195 | 176 | 8 | 573_DN | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 3246_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; HL60; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 3040_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 4956_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 7269_UP | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 2098_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 1301_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 7371_UP | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 4469_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 5386_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 6015_DN | |
| Drug | NSC339663 | 1.49e-04 | 250 | 176 | 9 | CID000003892 | |
| Drug | mantATP | 1.50e-04 | 35 | 176 | 4 | CID000123756 | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 2879_UP | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 2822_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 4767_DN | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 1705_DN | |
| Drug | Hb 7 | 1.55e-04 | 14 | 176 | 3 | CID000128180 | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 4825_DN | |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 1.59e-04 | 198 | 176 | 8 | 950_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 4090_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 7270_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 2316_DN | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 4808_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 5595_UP | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 5286_DN | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6501_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 5495_DN | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 3130_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 4501_UP | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7212_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 4346_DN | |
| Drug | carmustine; Down 200; 100uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 6888_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HG-U133A | 1.64e-04 | 199 | 176 | 8 | 1918_DN | |
| Drug | Ronidazole [7681-76-7]; Down 200; 20uM; HL60; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 6134_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7471_DN | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 5844_UP | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 3249_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 2175_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; HL60; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 1329_UP | |
| Drug | sulfonamide-3 | 1.77e-04 | 3 | 176 | 2 | CID009847197 | |
| Drug | homoveratric acid | 1.77e-04 | 3 | 176 | 2 | CID000007139 | |
| Drug | phthalazinone | 1.77e-04 | 3 | 176 | 2 | CID000008394 | |
| Drug | Etoposide | CDC42BPG NIBAN1 TRAF2 TGIF2 CENPF RIPK2 KEAP1 MSH6 INTS15 GPSM2 MACF1 IKBKB CADPS2 POLQ | 1.98e-04 | 587 | 176 | 14 | ctd:D005047 |
| Drug | CHEMBL154623 | 2.07e-04 | 38 | 176 | 4 | CID010457096 | |
| Drug | carvedilol | 2.63e-04 | 161 | 176 | 7 | CID000002585 | |
| Disease | MONILETHRIX | 1.88e-07 | 3 | 170 | 3 | 158000 | |
| Disease | Beaded hair | 1.88e-07 | 3 | 170 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 1.88e-07 | 3 | 170 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 7.48e-07 | 4 | 170 | 3 | C0546966 | |
| Disease | hair disease (is_implicated_in) | 3.30e-05 | 2 | 170 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Seckel syndrome | 2.67e-04 | 22 | 170 | 3 | C0265202 | |
| Disease | clonal hematopoiesis mutation measurement | 2.88e-04 | 55 | 170 | 4 | EFO_0020949 | |
| Disease | alpha fetoprotein measurement | 2.90e-04 | 100 | 170 | 5 | EFO_0010583 | |
| Disease | unipolar depression, bipolar disorder | 2.98e-04 | 156 | 170 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 3.26e-04 | 5 | 170 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 9.03e-04 | 33 | 170 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | non-melanoma skin carcinoma | 9.04e-04 | 265 | 170 | 7 | EFO_0009260 | |
| Disease | cup-to-disc ratio measurement | MTHFD1L DPH6 EHBP1L1 CROCC2 PLA2G6 AMOTL2 CCDC171 PLXNA1 SYMPK | 9.14e-04 | 430 | 170 | 9 | EFO_0006939 |
| Disease | Dermatitis, Atopic | 1.17e-03 | 36 | 170 | 3 | C0011615 | |
| Disease | Eczema, Infantile | 1.17e-03 | 36 | 170 | 3 | C0086196 | |
| Disease | osteoarthritis, hand | 1.26e-03 | 37 | 170 | 3 | EFO_1000789 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | macrovascular complications of diabetes | 1.44e-03 | 10 | 170 | 2 | EFO_0010977 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.44e-03 | 10 | 170 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.75e-03 | 11 | 170 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Situs Inversus | 1.75e-03 | 11 | 170 | 2 | C0037221 | |
| Disease | breast cancer (is_implicated_in) | 1.81e-03 | 150 | 170 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.92e-03 | 152 | 170 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | interleukin 17 measurement | 2.23e-03 | 45 | 170 | 3 | EFO_0008174 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.47e-03 | 13 | 170 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | EVC2 MTHFD1L SYNE1 PSMC5 JAKMIP2 ABCA10 FBXO30 KRT73 MSH6 ACTL9 DNAH8 | 2.61e-03 | 702 | 170 | 11 | C0009402 |
| Disease | response to antineoplastic agent | 2.62e-03 | 99 | 170 | 4 | GO_0097327 | |
| Disease | myopathy (implicated_via_orthology) | 2.69e-03 | 48 | 170 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | suntan | 3.02e-03 | 103 | 170 | 4 | EFO_0004279 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.30e-03 | 15 | 170 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.76e-03 | 16 | 170 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.76e-03 | 16 | 170 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.82e-03 | 110 | 170 | 4 | C4277690 | |
| Disease | Autistic Disorder | 4.15e-03 | 261 | 170 | 6 | C0004352 | |
| Disease | esophageal carcinoma, gastric carcinoma | 4.24e-03 | 17 | 170 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | copine-1 measurement | 4.24e-03 | 17 | 170 | 2 | EFO_0008102 | |
| Disease | posterior cingulate cortex volume measurement | 4.24e-03 | 17 | 170 | 2 | EFO_0010324 | |
| Disease | Drug habituation | 4.48e-03 | 115 | 170 | 4 | C0013170 | |
| Disease | Drug abuse | 4.48e-03 | 115 | 170 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.48e-03 | 115 | 170 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.48e-03 | 115 | 170 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.48e-03 | 115 | 170 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.48e-03 | 115 | 170 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.48e-03 | 115 | 170 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.48e-03 | 115 | 170 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.48e-03 | 115 | 170 | 4 | C0029231 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.54e-03 | 447 | 170 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Endometrial Neoplasms | 4.60e-03 | 58 | 170 | 3 | C0014170 | |
| Disease | Substance abuse problem | 4.62e-03 | 116 | 170 | 4 | C0740858 | |
| Disease | Myeloid Leukemia | 4.75e-03 | 18 | 170 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 4.75e-03 | 18 | 170 | 2 | C0023466 | |
| Disease | Polydactyly | 4.76e-03 | 117 | 170 | 4 | C0152427 | |
| Disease | skin sensitivity to sun | 5.29e-03 | 19 | 170 | 2 | EFO_0004795 | |
| Disease | Chronic myeloproliferative disorder | 5.29e-03 | 19 | 170 | 2 | C1292778 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 5.43e-03 | 194 | 170 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.55e-03 | 195 | 170 | 5 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSEVQRTMLELLNQL | 266 | P62195 | |
| RNIISLNMDLERDTQ | 11 | Q8N6Q1 | |
| IDRNLQVSLLAVDEM | 311 | Q8N1M1 | |
| AIQNQLARILAEFEM | 111 | Q6ZT62 | |
| LAQMEAVLRENARLQ | 311 | Q9Y2J4 | |
| DNLDLANVNLMLELL | 231 | Q8NHY2 | |
| DILQNRMALDILTAA | 376 | P60509 | |
| AENRRLEAEILALQM | 301 | Q96LX7 | |
| QIIEMELDSQEQLLL | 666 | Q9NR09 | |
| AQENMRLQELTDLLQ | 226 | Q5VTR2 | |
| LELERAQLEMQSQQL | 1196 | A6NC98 | |
| LITELMNERNTLQEE | 116 | Q99708 | |
| ANMLERAVNDQVLLD | 286 | Q96M83 | |
| LLIQLDFMRNLDSLD | 1091 | Q8WWZ4 | |
| LMEQLLDILDAQLQA | 576 | O94910 | |
| IMENIQELIRSAQEI | 281 | Q8NEB7 | |
| ELNNALLREEQAQML | 1041 | Q6TFL3 | |
| LLREEQAQMLLNEQA | 1046 | Q6TFL3 | |
| LIIIQSRLDQSMEEN | 336 | Q155Q3 | |
| QEDLLREMISSNIQA | 146 | Q7L8W6 | |
| ELQLQLALAMSREEA | 211 | Q9H201 | |
| NQLARILAEFEMTLE | 106 | Q9Y3L3 | |
| LSLEMRADLAQNVLL | 326 | Q8TC94 | |
| MEQLVDILDAQLQEL | 566 | O95490 | |
| EMLHEILLQAQRENL | 231 | P20594 | |
| RLQDFQELELVLMIS | 326 | Q6AI12 | |
| QELELVLMISENNFL | 331 | Q6AI12 | |
| AAMNQLLLQLREELA | 486 | Q8N283 | |
| FLNQAQIEVRLLELM | 196 | Q13627 | |
| QQLELSLQTLEMELR | 831 | Q9UPS8 | |
| EDMRSLEQAINLSLN | 191 | Q99467 | |
| DDVILLAAALRIQNM | 316 | Q6UB35 | |
| RMELILLLQESQQET | 2151 | Q9Y485 | |
| QDLEIRDRLATSQMN | 1646 | Q96BY7 | |
| QEIIQDLAAMVRELL | 636 | Q9UKV8 | |
| NEQMLDIACRLILNE | 486 | Q06278 | |
| MQVSQLDLFRLLDQN | 186 | Q9NXG6 | |
| NAANTILRQLDMELI | 236 | Q9P2K3 | |
| QLAAAQLELQMTALR | 201 | Q9UPQ7 | |
| NLMLLTLSTRDVQEN | 241 | Q99666 | |
| LLREIEATNAVLMEQ | 1671 | Q99666 | |
| NLMLLTLSTRDVQEN | 241 | O14715 | |
| LLREIEATNAVLMEQ | 1671 | O14715 | |
| LNSLQELQLLEIMCN | 66 | Q96N11 | |
| ELSLDRLAQALQVAM | 346 | Q96N11 | |
| LDISDRLENNQTRMA | 176 | Q2M385 | |
| ALQQELAMLREELRA | 786 | Q6DT37 | |
| NLFMDLLRESQLALI | 861 | Q92621 | |
| DCQILQERMELLQQA | 766 | Q96AA8 | |
| ELTARLNLSDLQMVL | 361 | P81274 | |
| LEEQLDRLMQQLQDL | 16 | Q8WZA0 | |
| ISDNMDRIRELIQQA | 2366 | Q16787 | |
| SIILSMDNNRNLDLD | 286 | Q86Y46 | |
| MDNNRNLDLDSIIAE | 291 | Q86Y46 | |
| IENSQLMEQLRLLVC | 21 | O95751 | |
| LQELQASMEQLLREQ | 1106 | Q96PY6 | |
| DSQEMVRLLLQAIQS | 586 | O14920 | |
| LQQALTERANMELQL | 391 | Q8TD10 | |
| ELNRMIQRLTAEIEN | 341 | P78386 | |
| DLLQEQLNRLESQMT | 1036 | Q9NS40 | |
| QIEMERLNHQAELLL | 6321 | Q03001 | |
| EELQLQLALAMSREV | 276 | O95208 | |
| EALLENMIQNILVEA | 1861 | Q6ZU64 | |
| LSMDNNRNLDLDSII | 301 | Q5XKE5 | |
| EINELNRMIQRLTAE | 321 | O43790 | |
| MDNNRNLDLDSIIAE | 296 | P19013 | |
| EQLVDQLIRDLNEMN | 96 | Q8N3Y1 | |
| LDDATMDLEQQRQLV | 1446 | Q7Z406 | |
| EAEMRNSILAQVLDQ | 36 | O14737 | |
| LQLQMDNLESRVALE | 1281 | Q9UIW2 | |
| LQLQMDNLESRVALE | 1256 | P51805 | |
| QLAMVERRANLLQAE | 1676 | Q9UKX2 | |
| LREALMQQLNSESLT | 76 | P56589 | |
| QNQVMREADLLQESL | 196 | Q6N069 | |
| TQELALLISRMQANA | 36 | Q92817 | |
| LLISRMQANADQVER | 41 | Q92817 | |
| DDIQQAINRMIQLTL | 901 | Q96JB1 | |
| RQDQLQLLMEEQDLE | 1421 | Q8N3D4 | |
| AQIILLIDNARMAVD | 141 | Q9C075 | |
| MLQALEELEIATLNR | 376 | Q86UK5 | |
| ELNRMIQRLTAEVEN | 156 | A6NCN2 | |
| VNELLMEAQLLQVSL | 1346 | Q9UGL1 | |
| TRTLQEMEAELQNLQ | 146 | Q8IXW0 | |
| QLAAENRLTEMETLQ | 861 | P35579 | |
| NELFLDVLESVNLLM | 171 | Q96CW1 | |
| LNAMERQLQSVAELE | 951 | Q9Y4D8 | |
| LLAENQVLMERLNQS | 216 | Q86VS8 | |
| QRMVLDAVTLNNLEI | 731 | P52701 | |
| EMLLQVNDQSLRLLD | 91 | Q9H6S3 | |
| RQESLQAILNRMEEV | 4456 | Q9UPN3 | |
| ETMENLNRVLLENVL | 846 | Q08462 | |
| IIVNRNREEMLLNSD | 371 | A1L0T0 | |
| ILELSTQARMELQQL | 346 | Q9UBT7 | |
| RELQMSEENQELVIL | 2161 | P49454 | |
| LNAQHQRLLEMLDTE | 251 | Q7Z6B0 | |
| LARQALQVEMEQLQS | 821 | H7BZ55 | |
| LQEMVADLELQQDLI | 1021 | O15360 | |
| AALIVEEARMILQQD | 876 | O75417 | |
| SNIMLENQSDRLREA | 1316 | A8TX70 | |
| QQMAELSEVLVLRLE | 361 | P54257 | |
| QLEQMILTEELQAIR | 601 | Q4G0X9 | |
| LADASQQLERLRQDM | 941 | Q9BV73 | |
| LRMLIDAQAEAAEQL | 426 | P52306 | |
| MQNEALVALALIAAL | 506 | P52306 | |
| LISRQEALELMNQNL | 76 | P43251 | |
| IEELRSSVNLLMANL | 306 | Q86UW7 | |
| LEEMQQRLQEALQLE | 431 | Q9H4E7 | |
| LLRLLLQSVVDANMN | 371 | O00462 | |
| ADRLEAEMQELAIQL | 501 | Q6ZW76 | |
| RVDLQQQIMTIIDEL | 36 | Q5SQI0 | |
| EAMEARLLLQLQDRQ | 386 | Q6ZN54 | |
| MEELQEQVALLTERL | 401 | O95466 | |
| IMNELRLSQQLCDVT | 66 | Q14145 | |
| LSQDLEALLSRMQAE | 146 | Q76NI1 | |
| QEALEMSRNRIAENL | 511 | Q9H078 | |
| QILLMNREVNAVELD | 3761 | Q9NYC9 | |
| LDNRNMEVQRLEALL | 421 | Q5M9N0 | |
| SQMLIVNEELQARLA | 596 | Q8TE68 | |
| EVAQLDMALALQDQR | 116 | Q8TB52 | |
| QNLNDLMLLQLDREA | 111 | P20160 | |
| LDELLQTRVLNQEEM | 26 | Q5EG05 | |
| NIEMTIENQEELRLL | 1076 | Q02224 | |
| MLELTNRLQESQEEI | 1571 | Q02224 | |
| INQELCRLNTMDLLL | 361 | O75170 | |
| EINELNRMIQRLTAE | 326 | P78385 | |
| NARVMLETQELLRQE | 1276 | Q8TEW0 | |
| ERDSMLLQQLLEQVQ | 851 | Q9P2E2 | |
| EINLDNAIDMIREAN | 911 | Q13423 | |
| NSVLQEEIAMLRLEL | 526 | Q86YR6 | |
| LRMANVALREELNAL | 11 | Q5HYW3 | |
| AARDVTLENRLQNME | 496 | P49591 | |
| TFLEDVLNEIQLRML | 391 | Q5T160 | |
| NLQVENVRDQALILM | 1701 | P46939 | |
| LRQQQLEDMIIDSLQ | 2326 | P46939 | |
| IRAMLEAQQEALEEL | 136 | Q9NQ50 | |
| LQEEMASLLQQIEIE | 66 | Q9H2W6 | |
| DLRAQLQILANMDSQ | 721 | Q96R06 | |
| MNTALNELRELERQS | 966 | Q7Z6B7 | |
| NALVLDALMRVANEE | 331 | Q8TEL6 | |
| ELLESQLRVASLQDM | 8601 | Q8NF91 | |
| NSMVVERQQLLQDLE | 906 | Q8N4C6 | |
| LQLEVDDLLTRVEQM | 1236 | Q9Y2K3 | |
| NLLDSMARNVVLDAL | 281 | Q96ME1 | |
| LAQMEINDSTRAILL | 2856 | Q8NFP9 | |
| MDSQVRVLELENELQ | 981 | O00291 | |
| MVEAEELAQLRLLNL | 1 | Q5JXC2 | |
| VQSILFDLNEAIMNR | 336 | O43166 | |
| QREMEALAAETNLLL | 106 | Q8WW24 | |
| LNNLELQDLMHISRA | 446 | O60733 | |
| TLELMEESLDINLLN | 111 | Q12769 | |
| LLQEIVDQCMNRSIA | 411 | O15269 | |
| LVEVALQRAAEMELQ | 201 | Q9GZN2 | |
| MAELLRSLQDSQLVA | 1 | Q8IWX5 | |
| DNQMLLLVAQRDRAS | 316 | Q8TE77 | |
| LRDLQRLEAMEAATQ | 286 | Q9UPE1 | |
| LNNIDRLANTITMIE | 606 | Q8IYE0 | |
| AALERVQMLEQQILA | 291 | Q8NFZ5 | |
| RIQESLDLMQLQDES | 616 | Q5VYP0 | |
| TLMLLDQNNREHVID | 431 | Q12933 | |
| NVQNILEMLLRLLDT | 816 | Q63HN8 | |
| LNLMNENIDILETAI | 51 | O95498 | |
| VQMSEQQLVELRADI | 321 | Q86XZ4 | |
| EAATLRNMNQLRAEE | 16 | Q9Y330 | |
| RMESILQALEDIQLD | 211 | Q9H2G4 | |
| LREEAILQMESNLLD | 421 | Q96NA8 | |
| REEALALMNRNLDIL | 46 | O95497 | |
| DEIQILSNLVMEELL | 236 | Q9BZQ8 | |
| MAAVLQQVLERTELN | 1 | P12270 | |
| LSQQIRVLLMELEEA | 496 | P12270 | |
| EQSLSVRALQEMLAN | 71 | Q15413 | |
| LNQSLDALLSRDLIM | 456 | O43353 | |
| EQLANIAMRQLLDNE | 246 | Q6ZT07 | |
| AQVLQELLSRIEMLE | 131 | Q92752 | |
| MQAQIAEESQIRIEL | 1091 | O75116 | |
| RLTQEMLENDLLQSH | 491 | Q9Y2I9 | |
| VRARNSMQLLEEANL | 331 | Q96NL6 | |
| IANLNMLLRDENVNV | 111 | Q92797 | |
| RLAQLEELSNRMVNA | 1216 | Q7Z4N2 | |
| EELSNRMVNALENLA | 1221 | Q7Z4N2 | |
| IDLSLIANDRFINML | 216 | O43592 | |
| NDMIQDLSRELANLL | 616 | Q96MP5 | |
| MASLALLQRQFDVDI | 96 | Q9UBQ0 | |
| NDTIARRIQELANDM | 871 | Q6R2W3 | |
| LAQLQETLELIDHMQ | 231 | Q00G26 | |
| ELALLLMEQDRNEEA | 551 | Q5SRH9 | |
| QQLELMALTISLQEE | 231 | Q8IWR1 | |
| QDLDEMNIEIIRNTL | 171 | P61421 | |
| LSMDNNRNLDLDSII | 306 | O95678 | |
| ILSMDNNRNLDLDSI | 286 | Q3SY84 | |
| EINELNRMIQRLTAE | 321 | Q14533 | |
| TRLTNENLDLMEQLE | 1406 | Q9Y4I1 | |
| LVQALMERNSELQAL | 666 | Q5VU43 |